PL2967013T3 - Mysz, w której zachodzi ekspresja ograniczonego repertuaru lekkiego łańcucha immunoglobuliny - Google Patents

Mysz, w której zachodzi ekspresja ograniczonego repertuaru lekkiego łańcucha immunoglobuliny

Info

Publication number
PL2967013T3
PL2967013T3 PL14717331T PL14717331T PL2967013T3 PL 2967013 T3 PL2967013 T3 PL 2967013T3 PL 14717331 T PL14717331 T PL 14717331T PL 14717331 T PL14717331 T PL 14717331T PL 2967013 T3 PL2967013 T3 PL 2967013T3
Authority
PL
Poland
Prior art keywords
light chain
immunoglobulin light
mice expressing
chain repertoire
limited immunoglobulin
Prior art date
Application number
PL14717331T
Other languages
English (en)
Inventor
Robert Babb
John Mcwhirter
Lynn Macdonald
Sean Stevens
Samuel Davis
David R. Buckler
Karolina A. Meagher
Andrew J. Murphy
Original Assignee
Regeneron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/798,455 external-priority patent/US9796788B2/en
Application filed by Regeneron Pharmaceuticals, Inc. filed Critical Regeneron Pharmaceuticals, Inc.
Publication of PL2967013T3 publication Critical patent/PL2967013T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46Hybrid immunoglobulins
    • C07K16/468Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/01Animal expressing industrially exogenous proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/90Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Environmental Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL14717331T 2013-03-13 2014-03-13 Mysz, w której zachodzi ekspresja ograniczonego repertuaru lekkiego łańcucha immunoglobuliny PL2967013T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/798,455 US9796788B2 (en) 2010-02-08 2013-03-13 Mice expressing a limited immunoglobulin light chain repertoire
PCT/US2014/026040 WO2014160202A1 (en) 2013-03-13 2014-03-13 Mice expressing a limited immunoglobulin light chain repertoire
EP14717331.4A EP2967013B1 (en) 2013-03-13 2014-03-13 Mice expressing a limited immunoglobulin light chain repertoire

Publications (1)

Publication Number Publication Date
PL2967013T3 true PL2967013T3 (pl) 2019-07-31

Family

ID=50483561

Family Applications (2)

Application Number Title Priority Date Filing Date
PL14717331T PL2967013T3 (pl) 2013-03-13 2014-03-13 Mysz, w której zachodzi ekspresja ograniczonego repertuaru lekkiego łańcucha immunoglobuliny
PL18210518.9T PL3501272T3 (pl) 2013-03-13 2014-03-13 Mysz eksprymująca ograniczony repertuar lekkiego łańcucha immunoglobuliny

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL18210518.9T PL3501272T3 (pl) 2013-03-13 2014-03-13 Mysz eksprymująca ograniczony repertuar lekkiego łańcucha immunoglobuliny

Country Status (26)

Country Link
EP (4) EP4218409B1 (pl)
JP (4) JP6529957B2 (pl)
KR (2) KR102295842B1 (pl)
CN (2) CN105188357B (pl)
AU (3) AU2014244020B2 (pl)
BR (1) BR112015022034B1 (pl)
CA (1) CA2903698C (pl)
CY (1) CY1121545T1 (pl)
DK (2) DK2967013T3 (pl)
ES (3) ES3013063T3 (pl)
FI (1) FI3501272T3 (pl)
HR (2) HRP20190706T1 (pl)
HU (2) HUE044003T2 (pl)
IL (2) IL240563B (pl)
LT (2) LT3501272T (pl)
MX (3) MX377146B (pl)
PL (2) PL2967013T3 (pl)
PT (2) PT2967013T (pl)
RS (2) RS58669B1 (pl)
RU (1) RU2689664C2 (pl)
SG (2) SG10201801101QA (pl)
SI (2) SI3501272T1 (pl)
SM (2) SMT201900196T1 (pl)
TR (1) TR201901668T4 (pl)
WO (1) WO2014160202A1 (pl)
ZA (2) ZA201505835B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2603559T5 (es) 2010-02-08 2021-02-22 Regeneron Pharma Cadena ligera común de ratón
US20130045492A1 (en) 2010-02-08 2013-02-21 Regeneron Pharmaceuticals, Inc. Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
US9796788B2 (en) 2010-02-08 2017-10-24 Regeneron Pharmaceuticals, Inc. Mice expressing a limited immunoglobulin light chain repertoire
FI3865581T3 (fi) 2011-08-05 2024-11-02 Regeneron Pharma Humanisoituja universaaleja kevytketjun hiiriä
KR102762747B1 (ko) 2011-10-17 2025-02-05 리제너론 파마슈티칼스 인코포레이티드 제한된 면역글로불린 중쇄 마우스
KR102266274B1 (ko) 2012-06-12 2021-06-17 리제너론 파마슈티칼스 인코포레이티드 제한된 면역글로불린 중쇄 유전자좌를 가지는 인간화된 비-인간 동물
TR201810255T4 (tr) * 2013-02-20 2018-08-27 Regeneron Pharma Modifiye edilmiş immunoglobulin ağır zincir sekanslarına sahip olan insan olmayan hayvanlar.
CA3124228C (en) 2014-03-21 2024-05-14 Regeneron Pharmaceuticals, Inc. Non-human animals that make single domain binding proteins
WO2016149678A1 (en) 2015-03-19 2016-09-22 Regeneron Pharmaceuticals, Inc. Non-human animals that select for light chain variable regions that bind antigen
CN108777951B (zh) 2016-01-13 2021-11-05 瑞泽恩制药公司 具有包括改造的多样性簇的免疫球蛋白重链可变区的非人动物及其用途
CA3076632A1 (en) * 2017-09-29 2019-04-04 Regeneron Pharmaceuticals, Inc. Bispecific antigen-binding molecules that bind a staphylococcus target antigen and a complement component and uses thereof
IL318469A (en) 2018-06-14 2025-03-01 Regeneron Pharma Non-human animals capable of reorganizing transgenic DH-DH, and their uses
US12467062B2 (en) 2018-12-21 2025-11-11 Compass Therapeutics Llc Transgenic mouse expressing common human light chain
CA3125380A1 (en) 2019-02-18 2020-08-27 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animals with humanized immunoglobulin locus
BR112021016173A2 (pt) 2019-02-22 2021-11-03 Regeneron Pharma Roedor geneticamente modificado, métodos de produção de um roedor geneticamente modificado e de produção de um anticorpo anti-nav1.7, célula ou tecido isolado de roedor, linhagem celular imortalizada, embrião de roedor, construto de ácido nucleico de direcionamento, e, hibridoma
KR20210095781A (ko) 2020-01-24 2021-08-03 주식회사 에이프릴바이오 항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물
CA3182925A1 (en) 2020-06-02 2021-12-09 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animals with common light chain immunoglobulin locus
CA3165366A1 (en) 2020-12-23 2022-06-30 Regeneron Pharmaceuticals, Inc. Nucleic acids encoding anchor modified antibodies and uses thereof
US12371487B2 (en) 2020-12-23 2025-07-29 Regeneron Pharmaceuticals, Inc. Methods for obtaining antibodies that bind transmembrane proteins and cells that produce the same
CN114736927A (zh) * 2022-05-19 2022-07-12 东北大学 一种单抗克隆与表达载体的构建及应用
TW202430641A (zh) * 2023-01-18 2024-08-01 美商基利科學股份有限公司 人類免疫球蛋白二元輕鏈轉殖基因構築體及其用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041871B1 (en) * 1995-10-10 2006-05-09 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US6774279B2 (en) 1997-05-30 2004-08-10 Carnegie Institution Of Washington Use of FLP recombinase in mice
US6737056B1 (en) 1999-01-15 2004-05-18 Genentech, Inc. Polypeptide variants with altered effector function
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7217797B2 (en) 2002-10-15 2007-05-15 Pdl Biopharma, Inc. Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
CN1852925A (zh) * 2003-07-15 2006-10-25 人类多克隆治疗公司 人源化免疫球蛋白基因座
DK1802193T3 (da) 2004-10-19 2014-06-10 Regeneron Pharma Fremgangsmåde til frembringelse af en homozygot mus til genetisk modifikation
AU2007235496B2 (en) * 2006-03-31 2013-11-21 E. R. Squibb & Sons, L.L.C. Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
PL2374818T3 (pl) 2006-06-02 2013-05-31 Regeneron Pharma Przeciwciała o wysokim powinowactwie przeciw ludzkiemu receptorowi IL 6
ITMI20071522A1 (it) 2007-07-27 2009-01-28 Areta Internat S R L Vaccino idiotipico
PL3456190T3 (pl) 2008-06-27 2022-06-06 Merus N.V. Wytwarzające przeciwciała transgeniczne zwierzę z gatunku myszy
AU2009329365B2 (en) * 2008-12-18 2016-01-14 Roger Kingdon Craig Non-human transgenic animals expressing humanised antibodies and use thereof
ES2865648T3 (es) 2009-06-26 2021-10-15 Regeneron Pharma Anticuerpos biespecíficos fácilmente aislados con formato de inmunoglobulina nativa
ES2603559T5 (es) 2010-02-08 2021-02-22 Regeneron Pharma Cadena ligera común de ratón
US20120021409A1 (en) * 2010-02-08 2012-01-26 Regeneron Pharmaceuticals, Inc. Common Light Chain Mouse
US20130045492A1 (en) * 2010-02-08 2013-02-21 Regeneron Pharmaceuticals, Inc. Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
CN104404050B (zh) * 2010-06-22 2018-06-08 瑞泽恩制药公司 杂交轻链小鼠
CA2807282A1 (en) * 2010-08-02 2012-02-09 Regeneron Pharamaceuticals, Inc. Mice that make binding proteins comprising vl domains
RU2460287C1 (ru) * 2011-03-29 2012-09-10 Государственное образовательное учреждение высшего профессионального образования "Российский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО РГМУ Росздрава) Трансгенная мышь, предназначенная для моделирования состояний, угрожающих развитием синдрома внезапной сердечной смерти при дистрофин-дефицитной кардиомиопатии
FI3865581T3 (fi) * 2011-08-05 2024-11-02 Regeneron Pharma Humanisoituja universaaleja kevytketjun hiiriä
GB201122047D0 (en) * 2011-12-21 2012-02-01 Kymab Ltd Transgenic animals

Also Published As

Publication number Publication date
EP3501272A1 (en) 2019-06-26
ES2942413T3 (es) 2023-06-01
SI2967013T1 (sl) 2019-03-29
MX377146B (es) 2025-03-07
HRP20230490T1 (hr) 2023-08-04
FI3501272T3 (fi) 2023-04-06
CN108611369B (zh) 2022-08-26
PT2967013T (pt) 2019-04-03
HUE044003T2 (hu) 2019-09-30
MX357308B (es) 2018-07-04
BR112015022034B1 (pt) 2023-02-28
EP4545567A3 (en) 2025-08-13
NZ711776A (en) 2021-09-24
SI3501272T1 (sl) 2023-05-31
EP2967013B1 (en) 2019-01-16
EP4218409C0 (en) 2025-02-12
EP4218409A2 (en) 2023-08-02
KR102424756B1 (ko) 2022-07-25
RS64185B1 (sr) 2023-05-31
JP2019076109A (ja) 2019-05-23
WO2014160202A1 (en) 2014-10-02
IL280892B1 (en) 2023-01-01
DK3501272T3 (da) 2023-04-03
JP2016512034A (ja) 2016-04-25
DK3501272T5 (da) 2024-09-02
HRP20190706T1 (hr) 2019-10-18
IL280892B2 (en) 2023-05-01
BR112015022034A2 (pt) 2017-08-29
PL3501272T3 (pl) 2023-07-03
SG11201506278RA (en) 2015-09-29
AU2014244020A1 (en) 2015-09-24
IL240563A0 (en) 2015-09-24
AU2020203238B2 (en) 2023-04-13
IL280892A (en) 2021-04-29
RU2019115237A (ru) 2019-06-11
SMT202300112T1 (it) 2023-05-12
AU2014244020B2 (en) 2020-06-04
ZA201505835B (en) 2019-09-25
CY1121545T1 (el) 2020-05-29
SG10201801101QA (en) 2018-04-27
EP3501272B1 (en) 2023-03-01
JP7010902B2 (ja) 2022-02-10
JP2019213549A (ja) 2019-12-19
CN105188357A (zh) 2015-12-23
HUE061977T2 (hu) 2023-09-28
LT2967013T (lt) 2019-04-25
WO2014160202A4 (en) 2014-11-13
KR20210107911A (ko) 2021-09-01
EP2967013A1 (en) 2016-01-20
KR20150126871A (ko) 2015-11-13
MX2015012539A (es) 2016-06-28
IL240563B (en) 2021-03-25
ES2712207T3 (es) 2019-05-09
CA2903698A1 (en) 2014-10-02
KR102295842B1 (ko) 2021-08-31
AU2020203238A1 (en) 2020-06-11
CN105188357B (zh) 2018-04-24
CN108611369A (zh) 2018-10-02
MX2020010837A (es) 2022-03-28
RS58669B1 (sr) 2019-06-28
RU2015143110A (ru) 2017-04-18
HK1218493A1 (en) 2017-02-24
ES3013063T3 (en) 2025-04-10
EP4218409A3 (en) 2023-08-30
AU2023202783A1 (en) 2023-05-25
TR201901668T4 (tr) 2019-02-21
JP6790136B2 (ja) 2020-11-25
CA2903698C (en) 2023-02-28
JP2020182490A (ja) 2020-11-12
SMT201900196T1 (it) 2019-05-10
DK2967013T3 (en) 2019-03-11
PT3501272T (pt) 2023-03-29
MX391010B (es) 2025-03-21
RU2689664C2 (ru) 2019-05-28
ZA201805369B (en) 2021-08-25
JP6529957B2 (ja) 2019-06-12
LT3501272T (lt) 2023-03-27
EP4545567A2 (en) 2025-04-30
EP4218409B1 (en) 2025-02-12

Similar Documents

Publication Publication Date Title
IL280892A (en) Mice expressing a restricted immunoglobulin light chain repertoire
HUE041878T2 (hu) Humanizált fõ hisztokompatibilitási komplexet expresszáló egerek
IL240562A0 (en) A mouse with a common light chain
GB2520939B (en) A Platform
GB2521962B (en) A light fitting
PL3033745T3 (pl) Urządzenie oświetleniowe
GB201312495D0 (en) A capo
DE112014004310A5 (de) Kettenführungselement
DE112014004457A5 (de) Kettenführungselement
GB201305228D0 (en) A Chain
GB201304231D0 (en) A Chain
GB201300689D0 (en) A Chain
GB2512339B (en) A capo
FR3003924B1 (fr) Transmission a variation continue
UY4362S (es) Configuración ornamental aplicada a un envase
UY4364S (es) Configuración ornamental aplicada a un envase
UY4363S (es) Configuración ornamental aplicada a un envase
FI20155875L (fi) Prosessi hiilivetyjen valmistamiseksi
ZA201404694B (en) A traffic light
GB201302164D0 (en) A sheath
TH148594B (th) เชนไกด์
FR3011726B3 (fr) Un grille-pain
UA27340S (uk) Балончик для соски-пустушки